Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in mice.
about
Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Docetaxel-carboxymethylcellulo ...... uced hepatic fibrosis in mice.
@en
Docetaxel-carboxymethylcellulo ...... uced hepatic fibrosis in mice.
@nl
type
label
Docetaxel-carboxymethylcellulo ...... uced hepatic fibrosis in mice.
@en
Docetaxel-carboxymethylcellulo ...... uced hepatic fibrosis in mice.
@nl
prefLabel
Docetaxel-carboxymethylcellulo ...... uced hepatic fibrosis in mice.
@en
Docetaxel-carboxymethylcellulo ...... uced hepatic fibrosis in mice.
@nl
P2093
P2860
P1476
Docetaxel-carboxymethylcellulo ...... uced hepatic fibrosis in mice.
@en
P2093
Bryan Hoang
Chih-Chun Chang
Dong-Yu Gao
Jia-Yu Liu
Joseph Bteich
Ling-Hsuan Chen
Po-Han Chao
Shyh-Dar Li
Tsaiyu Chiang
P2860
P304
P356
10.1080/1061186X.2017.1419358
P577
2017-12-18T00:00:00Z